Federal Policy | Behavioral Healthcare Executive Skip to content Skip to navigation

Federal Policy

FDA questions effect of abuse-deterrent opioids

June 13, 2017  |  Julie Miller, Editor in Chief

FDA aims to gather information to determine whether products with abuse-deterring formulations are having the intended impact.

New bipartisan bill revisits IMD issue

June 7, 2017  |  Julie Miller, Editor in Chief

The Medicaid Coverage for Addiction Recovery Expansion (CARE) Act would allow Medicaid payment to residential addiction treatment facilities with up to 40 beds—an increase over the current 16 bed limit. It would also allow for treatment services for up to...

Need for buprenorphine demonstrated in Medicaid data

June 7, 2017  |  Julie Miller, Editor in Chief

A new brief from the Urban Institute shows that Medicaid programs nationwide have seen increases in buprenorphine prescriptions since the launch of the Affordable Care Act, but trends are higher in expansion states.

How reversing net neutrality might affect your business

June 6, 2017  |  Julie Miller, Editor in Chief

One of the largest referral sources for addiction treatment centers is the internet, and that channel could see some changes this year. It’s surprising that more healthcare leaders haven’t weighed in on net neutrality.

What will stop patient brokering?

May 26, 2017  |  Julie Miller, Editor in Chief

We know catching the bad guy is too little too late—the patient has already been hurt by then. Maybe the real investment should be in educating the public with an unprecedented campaign.

Rumored gutting of ONDCP agenda does not materialize in president's budget plan

May 24, 2017  |  Gary A. Enos, Contributing Editor

Most core functions of the Office of National Drug Control Policy, including oversight of the Drug-Free Communities Support Program, are preserved in President Trump's fiscal 2018 budget proposal.

TCEM: 5 things to know about fraud investigations

May 19, 2017  |  BHE Staff

Attorney Anelia Shaheed recently spoke at the Treatment Center Executive & Marketing Retreat, highlighting critical information for every marketer and treatment center leader.

What to do when you receive a subpoena

May 18, 2017  |  Barrett Howell and Ryan Meyer

Here is a list of do’s and don’ts to follow in responding to federal government investigations of your healthcare organization.

4 questions we should be asking the White House

May 15, 2017  |  Julie Miller, Editor in Chief

President Trump and HHS Secretary Tom Price have identified three excellent priorities—childhood obesity, mental illness and the opioid epidemic—but their actions seem to be counterproductive. What do you think?

House narrowly approves AHCA

May 4, 2017  |  Tom Valentino, Senior Editor

The House on Thursday approved the American Health Care Act by a vote of 217-213. The legislation now heads to the Senate, where significant changes could be made.

Is the American Health Care Act rising from the dead?

May 3, 2017  |  Walter H. Boone

What does the rise of the American Health Care Act and the MacArthur Amendment mean for the alcohol and drug treatment industry?

The least you need to know about McCance-Katz

April 25, 2017  |  Julie Miller, Editor in Chief

President Trump nominated psychiatrist Elinore McCance-Katz for a new assistant secretary position, but some wonder if she will transform SAMHSA's accountability as envisioned.


Subscribe to Federal Policy